Abstract
Memory is an important cognition function, being fundamental to the development and independence of individuals. Our aim was to investigate the influence apolipoprotein E (APOE) and angiotensin I-converting enzyme (ACE) polymorphism and ACE inhibitors use, besides their interaction on memory performance of healthy subjects over 50 years. The sample consisted of 205 subjects assessed for five types of episodic memory, using Wechsler Memory Scale-Revised (WMS-R), who answered a questionnaire about drug use and were assessed for the ACE insertion/deletion polymorphism and APOE polymorphism. We found no influence of the APOE gene. The use of ACE inhibitors beneficially influenced learning ability scores (p = 0.02). Besides, I allele carriers of ACE polymorphism showed higher verbal memory scores compared with homozygous DD. Also, we observed an interaction influencing learning ability between the ACE polymorphism and the use of inhibitors, the beneficial influence of the I allele was present only in individuals who make use of ACE inhibitors. We conclude that the ACE gene has influence on memory performance, and that this influence is modulated by ACE inhibitors use.
Similar content being viewed by others
References
Amouyel P, Richard F, Cottel D, Amant C, Codron V, Helbecque N (1996) The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci Lett 217:203–205
Arbustini E, Grasso M, Fasani R, Klersy C, Diegoli M, Porcu E, Banchieri N, Fortina P, Danesino C, Specchia G (1995) Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J 74:584–591
Bartrés-Faz D, Junqué C, Clemente IC, López-Alomar A, Valveny N, López-Guillén A, López T, Cubells MJ, Moral P (2000) Angiotensin I converting enzyme polymorphism in humans with age-associated memory impairment: relationship with cognitive performance. Neurosci lett 290:177–180
Bartrés-Faz D, Junqué C, Clemente IC, Serra-Grabulosa JM, Guardia J, López-Alomar A, Sánchez-Aldeguer J, Mercander JM, Bargallo N, Olondo M, Moral P (2001) MRI and genetic correlates of cognitive function in elders with memory impairment. Neurobiol Aging 22:449–459
Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH (1986) The effects of antihypertensive therapy on the quality of life. N Engl J Med 314:1657–1664
Crook TH (2006) The memory advantage. SelectBooks, New York
Crook TH, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S (1986) Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change—report of a National Institute of Mental Health work group. Dev Neuropsychol 2:261–276
Cunha JA (2001) Manual da versão em Português das Escalas de Beck, 1st edn. Casa do Psicólogo, São Paulo
de Andrade FM, Larrandaburu M, Callegari-Jacques SM, Gastaldo G, Hutz MH (2000) Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer’s disease in a Southern Brazilian population. Br J Med Biol Res 33:529–537
De Blasi S, Montesanto A, Martino C, Dato S, De Rango F, Bruni AC, Mari V, Feraco E, Passarino G (2009) APOE polymorphism affects episodic memory among non demented elderly subjects. Exp Gerontol 44(3):224–227
Elias-Sonnenschein LS, Bertram L, Visser PJ (2012) Relationship between genetic risk factors and markers for Alzheimer’s disease pathology. Biomark Med 6(4):477–495
Farrer LA, Cupples LA, Haines J (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. Am Med Soc 278:1349–1356
Franken RA, Bellesso M, Cavazin AM, Polônio IB, Mattheucci E, Varga J (2004) Associação do polimorfismo do gene da enzima conversora da angiotensina com dados ecocardiográficos em jovens normotensos filhos de hipertensos. Rev Assoc Med Bras 50(1):62–67
Goldman WP, Morris JC (2001) Evidence that age-associated memory impairment is not a normal variant of aging. Alzheimer Dis Assoc Disord 15:72–79
Gustafson DR, Melchior L, Eriksson E, Sundh V, Blennow K, Skoog I (2010) The ACE insertion deletion polymorphism relates to dementia by metabolic phenotype, APOEepsilon4, and age of dementia onset. Neurobiol Aging 31(6):910–916
Hanon O, Seux ML, Lenoir H, Rigaud AS, Forette F (2004) Prevention of dementia and cerebroprotection with antihypertensive drugs. Curr Hypertens Rep 6:201–207
Hemming ML, Selkoe DJ (2005) Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J Biol Chem 280(45):37644–37650
Hou D-R, Wang Y, Zhou L, Chen K, Tian Y, Song Z, Bao J, Yang Q-D (2008) Altered angiotensin-converting enzyme and its effects in the brain in a rat model of Alzheimer Disease. Chin Med J 121(22):2320–2323
Isenberg D, Appel GB, Contreras G, Dooley MA, Ginzler EM, Jayne D, Sanchez-Guerrero J, Wofsy D, Yu X, Solomons N (2010) Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study. Rheumatology (Oxford) 49(1):128–140
Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P, Cantwell LB, Dombroski BA, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Lunetta KL, Martin ER, Montine TJ, Goate AM, Blacker D, Tsuang DW, Beekly D, Cupples LA, Hakonarson H, Kukull W, Foroud TM, Haines J, Mayeux R, Farrer LA, Pericak-Vance MA, Schellenberg GD (2010) Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 67(12):1473–1484
Kazama K, Anrather J, Zhou P, Girouard H, Frys K, Milner TA, Iadecola C (2004) Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res 95(10):1019–1026
Kehoe PG (2003) The renin-angiotensin-aldosterone system and Alzheimer s disease? Journal of the renin-angiotensin-aldosterone system. JRAAS 4(2):80–93
Lahiri DK, Nurnberger JI (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19(19):5444
Lee J, Chai S-Y, Mendelsohn FAO, Morris MJ, Allen AM (2001) Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7. Neuropharmacology 40(4):618–623
Lipp MEN (2000) Manual do inventário de sintomas de stress para adultos de Lipp. Casa do Psicólogo, São Paulo
Liu ME, Tsai SJ, Lu T, Hong CJ, Chen MC, Lin SL, Yeh HL, Ku YC (2011) No association of angiotensin I converting enzyme I/D polymorphism with domain-specific cognitive function in aged men without dementia. Neruomol Med 13(3):212–216
Lucatelli JF, Barros AC, Silva VK, Machado Fda S, Constantin PC, Dias AA, Hutz MH, de Andrade FM (2011) Genetic influences on Alzheimer’s disease: evidence of interactions between the genes APOE, APOC1 and ACE in a sample population from the South of Brazil. Neurochem Res 36(8):1533–1539
Malloy-Diniz LF, Lasmar VAP, Gazinelli LSR, Fuentes D, Salgado JV (2007) The Rey Auditory-Verbal Learning Test: applicability for the Brazilian eldery population. Rev Bras Psiquiatr 29:324–329
Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND, Brown MM (1995) Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke 26(8):1329–1333
McDougall GJ Jr, Becker H, Arheart KL (2006) Older adults in the SeniorWISE study at risk for mild cognitive impairment. Arch Psychiatr Nurs 20(3):126–134
Mogi M, Iwanami J, Horiuchi M (2012) Roles of brain angiotensin II in cognitive function and dementia. Int J Hypertens. doi:10.1155/2012/169649
Ohara T, Ninomiya T, Hirakawa Y, Ashikawa K, Monji A, Kiyohara Y, Kanba S, Kubo M (2012) Association study of susceptibility genes for late-onset Alzheimer’s disease in the Japanese population. Psychiatr Genet 22(6):290–293
Ohrui T, Matsui T, Yamaya M, Arai H, Ebihara S, Maruyama M, Sasaki H (2004) Angiotensin-converting enzyme inhibitors and incidence of Alzheimer’s disease in Japan. JAGS 52:649–650
Palumbo B, Cadini D, Nocentini G, Filipponi E, Fravolini ML, Senin U (1999) Angiotensin converting enzyme deletion allele in different kinds of dementia disorders. Neurosci Lett 267:97–100
Phillips MI, de Oliveira EM (2008) Brain renin angiotensin in disease. J Mol Med (Berl) 86(6):715–722
Richard F, Berr C, Amant C, Helbecque N, Amouyel P, Alpérovitch A (2000) Effect of the angiotensin I-converting enzyme I/D polymorphism on cognitive decline. Neurobiol Aging 21:75–80
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346
Rubinsztein DC (1995) Apolipoprotein E: a review of its roles in lipoprotein metabolism, neuronal growth and repair as a risk for Alzheimer’s disease. Psychol Med 25:223–229
Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop S, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele epsilon4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43(8):1467–1472
Schultz MR, Lyons MJ, Franz CE, Grant MD, Boake C, Jacobson KC, Xian H, Schellenberg GD, Eisen SA, Kremen WS (2008) Apolipoprotein E genotype and memory in the sixth decade of life. Neurology 70:1771–1777
Stewart R, Powell J, Prince M, Mann A (2004) ACE genotype and cognitive decline in an African-Caribbean population. Neurobiol Aging 25(10):1369–1375
Sudore RL, Landefeld CS, Perez-Stable EJ, Bibbins-Domingo K, Williams BA, Schillinger D (2009) Unraveling the relationship between literacy, language proficiency, and patient-physician communication. Patient Educ Couns 75(3):398–402
Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, Chalmers J, Group. PC (2003) Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163:1069–1075
Van der Elst W, van Boxtel MP, van Breukelen GJ, Jolles J (2005) Rey’s verbal learning test: normative data for 1855 healthy participants aged 24–81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc 11(3):290–302
van der Flier WM, Pijnenburg YAL, Schoonenboom SNM, Dik MG, Blankenstein MA, Scheltens P (2008) Distribution of APOE genotypes in a memory clinic cohort. Dement Geriatr Cogn Disord 25:433–438
Visscher PM, Tynan M, Whiteman MC, Pattie A, White I, Hayward C, Wright AF, Starr JM, Whalley LJ, Deary IJ (2003) Lack of association between polymorphisms in angiotensin-converting-enzyme and methylenetetrahydrofolate reductase genes and normal cognitive ageing in humans. Neurosci Lett 347(3):175–178
Weschler D (2004) WAIS-III: Escala de inteligência Wechsler para adultos. WMS-III: Escala de memória Wechsler—manual técnico (trans: Silva MCdVM). Casa do Psicólogo, São Paulo
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Schuch, J.B., Constantin, P.C., da Silva, V.K. et al. ACE polymorphism and use of ACE inhibitors: effects on memory performance. AGE 36, 1515–1522 (2014). https://doi.org/10.1007/s11357-014-9646-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-014-9646-z